The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,930,208 in first-year total cost, median $592,360.
Most frequent study sections
- Clinical Research and Field Studies of Infectious Diseases Study Section[CRFS]4
- Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section[DDR]3
- Bacterial Pathogenesis Study Section[BACP]2
- Macromolecular Structure and Function A Study Section[MSFA]1
- Prokaryotic Cell and Molecular Biology Study Section[PCMB]1
Most frequent institutions
- WASHINGTON UNIVERSITY3
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- CEDARS-SINAI MEDICAL CENTER1
- EMORY UNIVERSITY1
- HARVARD SCHOOL OF PUBLIC HEALTH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Microbial Community Disruption Following Topical Antimicrobial Application in Staphylococcus aureus-Affected Households1R01AI163161-01 | FRITZ, STEPHANIE ANNWYLIE, KRISTINE M. | WASHINGTON UNIVERSITY, MO | $785,082 | CRFS |
| 2021 | Impact of early-life perturbations on pediatric microbiome maturation1R01AI155893-01A1 | DANTAS, GAUTAM | WASHINGTON UNIVERSITY, MO | $756,349 | CRFS |
| 2021 | Targeting Clostridioides difficile with microbiome-sparing, resistant-proof anti-toxins1R01AI150971-01A1 | SCHRAMM, VERN L. | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $668,741 | MSFA |
| 2021 | Mechanism of Colonization Resistance2R01AI112949-05A1 | BAUMLER, ANDREAS JTSOLIS, RENEE M | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $547,932 | ZRG1 |
| 2020 | Exploitation of multiple heteroresistance for effective antibiotic combination therapy1R01AI148661-01A1 | WEISS, DAVID S | EMORY UNIVERSITY, GA | $823,339 | DDR |
| 2020 | Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae1R01AI153521-01 | GRAD, YONATAN HJERSE, ANN E.NICHOLAS, ROBERT A | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $796,194 | DDR |
| 2020 | Molecular mechanisms of hypervirulence in antibiotic-resistant Pseudomonas aeruginosa1R01AI146425-01A1 | JORTH, PETER ALLAN | CEDARS-SINAI MEDICAL CENTER, CA | $592,360 | BACP |
| 2020 | Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients1R01AI151038-01 | SATLIN, MICHAEL JOSEPH | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $572,183 | CRFS |
| 2020 | Surprising Efficacy of Discounted Antibiotics vs. MDR Gram-Negative Pathogens Occurring Through Innate Immune Sensitization1R01AI145310-01A1 | KUMARASWAMY, MONIKANIZET, VICTOR | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $472,625 | ZRG1 |
| 2020 | Evolution and consequences of multidrug resistant ribosome1R01AI150986-01A1 | YAP, M.-N. FRANCES | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $462,841 | PCMB |
| 2020 | A strategy for new regimens to treat pulmonary Mycobacteroides abscessus infection1R01AI155664-01 | LAMICHHANE, GYANU | JOHNS HOPKINS UNIVERSITY, MD | $412,731 | DDR |
| 2019 | Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumannii1R01AI144120-01 | FELDMAN, MARIO | WASHINGTON UNIVERSITY, MO | $621,666 | BACP |
| 2019 | Bacterial Characteristics of Community-associated Carbapenem-Resistant Enterobacteriaceae1R01AI143910-01 | VAN DUIN, DAVID | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $418,165 | CRFS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.